Patents Represented by Attorney, Agent or Law Firm Molly A. Holman
  • Treatment of acute coronary syndrome with GLP-1
    Patent number: 6706689
    Abstract: The invention relates to methods for treating a patient suffering from acute coronary syndrome, but who is not suffering from a Q-wave myocardial infarction, comprising administration of a therapeutically effective amount of a GLP-1 molecule. The GLP-1 can be self-administered, and can be administered in one or more doses, as needed, on an intermittent or continuous basis, to optimize metabolism in cardiac tissue and to prevent cardiac damage associated with ischemia.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: March 16, 2004
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Thomas R. Coolidge, Mario Ehlers